GLP1R and retinal disorder: Conversely, patients with a PMH of dyslipidemia (OR 0.45; 95% CI 0.31–0.66) or retinopathy (OR 0.36; 95% CI 0.19–0.67) had lower odds of being underprescribed either SGLT2i or GLP-1 RA.